Indian Air Force Medical Supplies Tender Medicines & Injectables 2026 – 43 Items, ₹493610 Estimated Value

Tender Overview

The Indian Air Force invites bids for a comprehensive medical supplies package comprising 43 items of pharmaceuticals and related products, including Nebivolol 5mg, Digoxin 0.25 mg/0.5 mg, various injections (e.g., Vasopressin 20 units/ml, Dopamine HCl 40 mg/ml), antihypertensives, antibiotics, eye/ear preparations, and supportive formulations. Estimated value is ₹493,610 with several items catalogued in the BOQ. The procurement targets centralized stocking for medical readiness, with a broad product mix spanning tablets, injectables, eye drops, ointments, and mouth rinses. The tender documents include a clause enabling quantity variation up to 25%, at contracted rates, across both initial and extended delivery periods. A specific ATC adjustment note clarifies carboprost tromethamine 250 mcg/ml strength for 1 ml injections. Unique aspects include a substantial line-item diversity and a pre-approval path for OEM/ATC variations. The tender is positioned as a government medical procurement opportunity for the IAF’s clinical supply chain. Keyword-rich tender in India’s defense medical segment targets pharmaceutical distributors and hospital suppliers with established compliance capabilities.

Technical Specifications & Requirements

• 43 items comprising medicines, oral suspensions, eye/ear preparations, gels and ointments, and injections (e.g., Nebivolol, Digoxin, Hydrocortisone combos, Labetalol, Ramipril, Enalapril, Spironolactone, Dorzolamide/Timolol, Timolol eye drops, Misoprostol, Carboprost 1 ml with noted correction to 250 mcg/ml).
• No explicit item-level technical specs beyond names; an ATC note references dose strength correction for a specific injection.
• Estimated contract value: ₹493,610; delivery/commercial terms include a 25% quantity variation option.
• Notable product categories include cardiac/antihypertensive agents, anti-ulcerants, analgesics, ophthalmic preparations, antibiotics, gynecological agents, and supportive care items.
• At least one item requires clarification/ATC documentation (carboprost tromethamine) per appended ATC file.
• No standard or ISO/BIS specifications are itemized in the data; the scope emphasizes supply readiness and regulatory alignment.

Terms, Conditions & Eligibility

• EMD: Not disclosed in the available terms; bidders should verify with the procuring authority.
• Delivery window: Delivery period mechanics present via option clause; final schedule to be determined with order placement.
• Quantity variation: Purchaser may increase/decrease up to 25% of bid/contract quantity.
• Delivery extension: Additional time computed as (Increased quantity ÷ Original quantity) × Original delivery period, with a minimum of 30 days.
• ATC/documentation: An ATC document has been uploaded and referenced for carboprost tromethamine strength correction.
• Eligibility & documentation: Standard bidder documents required (GST, PAN, experience, financials) to be verified per purchaser’s terms; OEM authorizations may be required per item and strength adjustments.
• Payment & penalties: Not specified in the excerpt; bidders should request the complete buyer terms before submission.
• Warranty/AMC: Not explicitly stated in the available data; confirm with the buyer during bid preparation.